Chris Champlin – Vice President & General Manager for the Growth, Protection and Separations business unit of Thermo Fisher Scientific
Thermo Fisher is at the heart of the global response to COVID-19. They are working with government agencies and researchers to ensure priority access to instruments, consumables, safety supplies and other products to address the outbreak–particularly in analysis of the virus, diagnosis and personal protection. From clinical trials, manufacturing, PPP, to storage resources, channel management and more, they are a key player for all facets of protection, testing and eventually, vaccinations.
